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Risk Factors for Non-Procedure Related Mortality One
Year after Thoracic Endovascular Aortic Repair
Asad A. Shah, Damian M. Craig, Judson B. Williams,
Syamal D. Bhattacharya, Nicholas D. Andersen, Svati H.
Shah, Richard L. McCann, G. Chad Hughes. Surgery,
Duke University Medical Center, Durham, NC
Objectives: Thoracic endovascular aortic repair
(TEVAR), although physiologically well tolerated, may fail
to confer significant survival benefit in some high-risk pa-
tients. This study sought to determine risk factors for
one-year non-procedure related mortality after TEVAR.
Methods: A single-institution, prospective cohort re-
view was performed of all patients undergoing TEVAR
between 5/2002-12/2010. Univariate analysis and multi-
variable Cox proportional hazards regression were used to
identify risk factors associated with one-year non-operative
mortality (NOM), defined as death between post-operative
day (POD) 31 and 365. For patients with multiple proce-
dures, the index procedure was used for survival analysis.
Results: 282 patients underwent at least one TEVAR
procedure during the study interval; index procedures in-
cluded descending (n189), hybrid arch (n55), and
hybrid thoracoabdominal repair (n38). Mean follow-up
was 2420 months and 100% complete. 30-day/in hospi-
tal mortality was 7.4% and one-year NOM was 11.7%. The
most common cause of death between POD 31-365 was
cardiopulmonary (n12/33 [36%] late deaths). Univariate
predictors of one-year NOM were ASA class (P0.001),
BMI (P0.004), aortic diameter (P0.005), weight
(P0.005), race (P0.011), history of stroke (P0.014),
age (P0.019), and peripheral vascular disease (P0.032).
Multivariable modeling (Table 1) demonstrated six inde-
pendent predictors of one-year NOM, with these variables
explaining the majority of risk (C statistic0.83).
Conclusions: ASA Class 4, white race, male sex, de-
creased weight, history of stroke, and increased aortic di-
ameter independently predict one-year NOM after TE-
VAR. These clinical characteristics may help identify
patients unlikely to derive long-term survival benefit from
TEVAR.
Table 1.
Variable
Living
Group
(n  228)
POD 31-1yr
Mortality
Group
(n  33)
Hazard Ratio
[95% Confidence
Interval] P
ASA Class (4) 96 (47%) 24 (73%) 3.56 [1.43-8.88] 0.007
Race (white) 142 (62%) 28 (85%) 3.84 [1.44-10.22] 0.007
Sex (male) 131 (57%) 24 (73%) 3.10 [1.30-7.36] 0.010
History of Stroke 20 (9%) 8 (24%) 2.85 [1.24-6.55] 0.014
Weight (kg) 83  19 73  10 0.97 [0.94-0.99] 0.014
Aortic Diameter
(cm)
5.52  1.63 6.43  1.92 1.27 [1.03-1.56] 0.023
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with Abdominal Aortic Aneurysms
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T. Voûte1, Sanne E. Hoeks1, Don Poldermans1. 1Vascular
Surgery, Erasmus Medical Centre, Rotterdam, Nether-
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Objectives: Although patients undergoing endovascu-
lar treatment (EVAR) of their abdominal aortic aneurysm
have a better survival and quality of life (QoL) in the first
month after surgery, it has been thought that in patients
who survive this first month, there is a difference in long
term QoL between those who underwent an EVAR and
those who received open repair (OR). This assumption was
based on the fact that EVAR patients undergo an extensive
Aortic flow waveforms (first row, in ml/sec) and average wall
motion (second row, in mm) together with axial cross section of
aorta and IMH (third row) for IMH patient #1. Arrows denote
location where thickness measurement was taken. Number in
figure is thickness of IMH. Table presents wall compliance (CC:
absolute correlation coefficient with aortic flow waveform, IMH
thickness, maximum contraction and maximum extension).
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follow-up with repeated CT-scans and accompanying un-
certainties, where open repair patients often get discharged
from follow up, 6 months after surgery. The aim of the
current study was to compare disease specific health-status
(HS) and long term quality of life (QoL) after EVAR and
OR of an abdominal aortic aneurysm (AAA).
Methods: Between May and December 2004, pro-
spective enrolments took place at 11 hospitals across the
Netherlands. A total of 337 patients had a follow-up of 5
years after elective aneurysm repair. Of these, 186 under-
went EVAR and 151 underwent OR. HS and long term
QoL were assessed by the Peripheral Artery Questionnaire
(PAQ), 3 and 5 years postoperatively.
Results: After both 3 and 5 years, there were no
statistical differences in Physical Limitation Score (PLS)
(p0.34 and p0.65 for 3 and 5 years, respectively),
Perceived Disability Score (PDS) (p0.66 and p0.95),
Treatment Satisfaction Score (TSS) (p0.65 and p0.90)
or the Summary Score, a combined score of PLS and PDS,
(p0.39 and p0.97) between both groups. Neither
group showed a clinically relevant declination of 8 points
for any of the domains.
Conclusions: In the first 5 years after treatment, dis-
ease specific health-status and quality of life do not differ in
patients who underwent endovascular or open repair of an
abdominal aortic aneurysm, despite a more extensive fol-
low-up in EVAR patients. Furthermore, there was no de-
cline in HS and QoL between 3 and five years after surgery
in both groups.
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Retrograde Ascending Aortic Dissection as an Early
Complication of Thoracic Endovascular Aortic Repair
Judson B. Williams, Jonathan P. Piccini, Syamal D. Bhat-
tacharya, Nicholas D. Andersen, Richard L. McCann, G.
Chad Hughes. Duke University, Durham, NC
Objectives: Retrograde ascending aortic dissection
(rAAD) is a potential complication of thoracic endovascular
aortic repair (TEVAR), yet little data exists regarding the
incidence, etiology, and outcome of this event.
Methods: A prospective institutional database was
used to identify cases of acute rAAD following TEVAR
from a cohort of 309 consecutive procedures from
7/2005-9/2010. The database was analyzed for postop-
erative rAAD as well as relevant patient and operative
variables. In addition, review of the FDAManufacturer and
User Facility Device Experience (MAUDE) registry was
undertaken to identify reported rAAD cases in 2009-2010.
Results: The incidence of rAADwas 1.9% (n6/309);
all were identified in the perioperative period (range 0-6
days) with 33%(2/6) 30 day/in-hospital mortality. 83%
(5/6) underwent emergent repair; 1 patient died without
repair. rAAD patients were similar to the non-rAAD group
(n303) across pertinent variables including age, sex, race,
and device size (all P0.1). rAAD incidence by aortic pathol-
ogy was: 1.1%(2/183) for aneurysm, 3.8% (4/104) for dis-
section, and 0% (0/22) for transection. rAAD incidence by
devicewas: TAG(Gore) 1.0%, n2/205;Talent (Medtronic)
4.7%, n2/43; and Zenith TX2 (Cook) 3.6%, n2/55.
Patients with proximal landing zone in native ascending aorta
(zone 0) had an incidence of 7.4% (2/27) vs. 1.4% for all
others (4/282), p0.09. Definitive diagnosis was by CTA
(n1), intraoperative transesophageal echo (TEE) (n3),
intraoperative arteriography (n1), or postmortem au-
topsy (n1). The MAUDE registry revealed 9 FDA-re-
ported cases of rAAD in 2009-2010 with 56%(5/9) follow-
ing TEVAR for dissection and 1 confirmed death (11%
mortality).
Conclusions: rAAD is a lethal early complication of
TEVAR, which may be more common when treating dis-
section, with devices utilizing proximal bare springs or
barbs for fixation, and with zone 0 proximal landing zone.
Intraoperative TEE assessment of the ascending aorta
should be mandatory following TEVAR to avoid
under-recognition.
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Spiral and Non-Spiral Type B Dissections: Thrombosis
and Aortic Growth Rates
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Herwaarden2, Santi Trimarchi3, Jeffrey Indes1, Frans L.
Moll2, Bart E. Muhs1. 1Section of Vascular Surgery, Yale
University School of Medicine, New Haven, CT; 2Univer-
sityMedical Center, Utrecht, Netherlands; 3Policlinico San
Donato IRCCS, Milan, Italy
Objectives: The false lumen shape in type B dissection
patients might be of influence on the thrombosis and aortic
growth rates during FU.We have observed patients wherein
the false lumen stays continuously on the same side and
patients wherein the false lumen runs spirally around the
aorta. The purpose of this study is to evaluate the throm-
bosis and aortic growth rate of spiral and straight type B
dissections.
Methods: Type B dissection patients with a CTA ob-
tained directly after presentation and a subsequent CTA
obtained at least 30 days following medical treatment were
included (2000-2010). Diameters of the aortas were mea-
sured at 8 levels on the baseline and last available FU CTA,
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